Graphite Bio declares special $1.03/share dividend tied to Lenz merger

LENZ Therapeutics, Inc.

Special dividend estimated at $1.03 per share, capped at $60M.
Record date March 18, 2024; payment date March 21, 2024.
Dividend contingent on closing of merger with Lenz Therapeutics.
Graphite stockholders vote on merger at special meeting March 14, 2024.

item 7.01 item 9.01

LENZ Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-063785

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.